| November
29, 2001
An award in the amount
of $25,000 was provided to support islet cell transplantation trials
at the Islet Cell Transplantation Lab at the Barbara Davis Center.
This support will ensure an on-call surgeon is available to help
in the procurement of pancreases for transplantation. Many of the
researchers and physicians in this promising trial have children
with diabetes or they have Type I diabetes themselves. Most of the
team was trained at Edmonton. This trial will compare the success
of islet cell transplantation in Type I patients and patients with
CFRD. This will provide information on the role of autoimmunity
in transplantation success.
See The following abstracts
for more information on this exciting research
An essential contribution
by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet
allografts.
Diamond AS, Gill RG.
click
here to view
alpha4 integrin in
islet allograft rejection.
Stegall MD, Dean PG,
Ninova D, Cohen AJ, Shepard GM, Gup C, Gill RG.
click
here to view
The basis of immunogenicity
of endocrine allografts.
Nicolls MR, Coulombe
M, Gill RG.
click
here to view
Donor IFN-gamma receptors
are critical for acute CD4(+) T cell-mediated cardiac allograft
rejection.
Wiseman AC, Pietra BA,
Kelly BP, Rayat GR, Rizeq M, Gill RG.
click
here to view
Immunobiology of cardiac
allograft and xenograft transplantation.
Pietra BA, Gill RG.
click
here to view
Mechanisms of insulin
resistance in cystic fibrosis.
Hardin DS, Leblanc A,
Marshall G, Seilheimer DK.
click
here to view
Back
to Research Updates
|
